---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-041546"
form_type: "8-K"
ticker: "CURX"
cik: "0002025942"
company_name: "Curanex Pharmaceuticals Inc"
filed_at: "2026-09-04T20:15:30+00:00"
generated_at: "2026-09-04T20:16:05.638837+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Curanex regains Nasdaq minimum bid price compliance after 1-for-20 reverse split

## Summary
- On Sept 3, 2026, Nasdaq confirmed closing bid price >= $1.00 for 10 straight business days (Aug 20-Sep 2).
- Company effected 1-for-20 reverse stock split on Aug 20, 2026 to cure bid price deficiency.
- Originally notified Nov 5, 2025 of non-compliance with Nasdaq Listing Rule 5550(a)(2).
- Nasdaq has closed the matter; CURX remains listed on The Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-26-041546
- form_type: 8-K
- ticker: CURX
- cik: 0002025942
- company_name: Curanex Pharmaceuticals Inc
- filed_at: 2026-09-04T20:15:30+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2025942/000149315226041546/0001493152-26-041546-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2025942/000149315226041546/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-041546
- JSON: https://secwatch.observer/filing/0001493152-26-041546.json
- Plain text: https://secwatch.observer/filing/0001493152-26-041546.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.